Sign in to view content

Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results

David A. Eichenbaum, MD, FASRS

Video
Published 2021

Related

Twelve Month Safety and Efficacy Outcomes from a Phase 2 Study of APL-2 in Patients with Geographic Atrophy
David S. Boyer, MD
Updates from the Field
2017
Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular Age-Related Macular Degeneration in High Risk Eyes
Jeffrey S. Heier, MD
Updates from the Field
2019
Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting
Kamal Kishore, MD, MBBS
Annual Meeting Talks
2022

Category: Pharmacology

See more